Det firma, der fremstiller INCRELEX, vil udføre en langtidsundersøgelse af lægemidlets sikkerhed, idet behandlingen begynder, mens patienterne er små børn, og fortsætter ind i voksenalderen.
The company that makes INCRELEX will carry out a long-term study looking at the safety of the medicine, when treatment is started in young children and continued into adulthood.